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Abstract
Hepatitis D virus (HDV) infection plays an important role in liver diseases. However, the
molecular epidemiology and impact of HDV infection in chronic hepatitis B (CHB) remain
uncertain in Vietnam. This cross-sectional study aimed to investigate the prevalence and
genotype distribution of HDV among HBsAg-positive patients in Central Vietnam. 250 CHB
patients were tested for HDV using newly established HDV-specific RT-PCR techniques.
HDV genotypes were determined by direct sequencing. Of the 250 patients 25 (10%) had
detectable copies of HDV viral RNA. HDV-2 was predominant (20/25; 80%) followed by
HDV-1 (5/25; 20%). Proven HDV genotypes share the Asian nomenclature. Chronic hepati-
tis B patients with concomitant HDV-1 showed higher HBV loads as compared to HDV-2
infected patients [median log10 (HBV-DNA copies/ml): 8.5 vs. 4.4, P = 0.036]. Our findings
indicate that HDV infection is highly prevalent and HDV-2 is predominant in Central Viet-
nam. The data will add new information to the management of HBsAg-positive patients in a
highly HBV endemic region to in- or exclude HDV infection in terms of diagnostic and treat-
ment options.
Introduction
Hepatitis D, caused by the hepatitis Delta virus (HDV) is a unique RNA pathogen, which
needs hepatitis B virus (HBV) envelope proteins to infect the hepatocytes. HBV-HDV coinfec-
tion can accelerate the liver diseases [1–4]. Among 250 million chronic HBsAg carriers world-
wide [5], approximately 12.5 million individuals had been coinfected with HDV [6].
HDV is a small single-stranded negative-sense circular RNA virus which encompasses a
spherical “HDAg and HBsAg-hybrid” particle of ~36 nm in diameter, and an outer envelope
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containing hepatitis B surface antigens (HBsAg) [7, 8]. The HDV genome consists of approx.
1680 nucleotides covered by approximately 200 hepatitis D antigen molecules (HDAg) [2, 9].
HDV needs the presence of HBV envelope proteins for its assembly, propagation, and trans-
mission to initiate new rounds of infection [6, 10]. However, HDV can replicate within non
HBV infected hepatocytes since no helper function for HDV RNA synthesis and RNP assem-
bly is required by HBV [10, 11]. The open reading frame of HDV encodes unique delta anti-
gens, the small and the large isoforms of S-HDAg and L-HDAg. The S-HDAg is responsible
for HDV replication initiation, whereas the L-HDAg is required for viral packaging [10, 12].
HDV can be acquired either as a coinfection with acute hepatitis B or as a super infection espe-
cially in chronically HBV infected individuals [13].
HDV viruses have been separated into at least eight major clades based on their genome
diversity, with specific geographic distribution [6, 14]. HDV-1 is the frequently occurring
clade and is distributed among Europe, Middle East, America and North Africa [15–18].
HDV-2 to HDV-8 occur regionally [19]. For instance, HDV-2 prevails in countries like Japan
[20], Taiwan [21, 22] and Russia [23]. HDV-3 which is a most diverged genotype is exclusively
found in South America [18, 24, 25]. HDV-4 is reported across Japan and Taiwan [21];
whereas HDV-5 to HDV-8 are described in Africa [26, 27].
The distribution of HDV varies with different geographical regions with a higher incidence
in Middle East, Mediterranean, Amazonas, African, and in Asian countries [6, 14, 28]. Viet-
nam is a South-East Asian country with a high prevalence of HBV infection and approximately
10–20% of general populations live with chronic hepatitis B [29, 30]. High prevalence of HDV
is reported in HBsAg positive patients in Northern provinces of Vietnam, especially in patients
with acute hepatitis B with up to 43% [31]. The previous study reported that 15% of HBV
patients were positive for HDV-RNA and HDV-2 is predominant in this specific region [31].
In contrast, another studies conducted in two rural districts from Northern Vietnam reported
a low HDV prevalence (1%) in HBsAg positive individuals [32]. Although studies have shown
considerable proportion of HDV-HBV coinfection in Northern provinces, no studies exist till
date on the prevalence of HDV-HBV coinfection in Central and South provinces of Vietnam.
Therefore, this study aimed to investigate the prevalence and genotype distribution of HDV in
HBsAg-positive patients in Central Vietnam. Furthermore, HDV genotypes were correlated
with clinical aspects in HBV-HDV coinfected patients.
Materials and methods
Study subjects
A total of 250 chronic hepatitis B patients were recruited for this cross-sectional study from
March to June 2015. The study subjects visited for blood checking or admitted for the treat-
ment in the Hoan My hospital, Da Nang, Vietnam. These patients were from three South Cen-
tral provinces, namely Da Nang, Quang Nam, and Quang Ngai provinces.
The inclusion criteria were HBV patients positive for HBsAg and negative for anti-HCV
and anti-HIV antibodies as determined by ELISA assays (Diagnostic automation/Cortez Diag-
nostics, Inc., Woodland Hills, California, USA). Patients with other relevant liver diseases such
as autoimmune hepatitis, alcoholic or toxic liver disease, and hemochromatosis were excluded
from the study. All HBV patients were treatment naïve. All patients did not present cirrhosis
and/or liver cancer. The clinical parameters were collected, including ALT, AST, total biliru-
bin, direct bilirubin. Five ml of venous blood were collected from all participants at the time of
visit or admission. Serum or plasma was separated from blood and used for biochemical and
other laboratory routine procedures. Samples were stored at -80˚C until further use.
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Ethics statement
Informed written consent was obtained after detailed explanation of the study at the time of
sampling from all participants or from their parents if subjects were less than 18 years. The
study was approved by the institutional review board of the Hoan My Hospital, Da Nang, Viet-
nam and from Duy Tan University, Da Nang, Vietnam.
Viral nucleic acid extraction and cDNA synthesis
Nucleic acid (DNA and RNA) were extracted from 200 μL sera using High Pure Viral Nucleic
Acid kit (Roche Diagnostics GmbH, Mannheim, Germany) following the manufacturer’s
instruction and stored until use in aliquots at -80˚C. Synthesis of cDNA was performed using
First Strand cDNA Synthesis Kit for RT-PCR (Roche GmbH, Mannheim, Germany) following
the manufacturer’s instructions.
Molecular detection and genotyping of HDV
HDV-specific nested PCRs were performed with reverse transcribed cDNA samples as tem-
plate using four highly conserved primer pairs representing all eight HDV genotypes as previ-
ously described [31]. HDV nomenclature was according recent reports [26, 33]. The first round
of the PCR amplification was performed with 100 ng of cDNA using the FastStart PCR Master
Kit (Roche Diagnostics GmbH, Mannheim, Germany) and primer pairs HDV57-F and HDV60-
R (nucleotide 299 to 770 as referred to NC001653). The amplicons from first round were used as
templates for the subsequent second PCR using primer pairs HDV48-F and HDV54-R targeting
specific regions in the HDV genome. The details of primer pairs employed and specific regions
along with necessary conditions are described in Table 1.
In order to determine HDV genotypes the L-HDAg (nucleotides 888 to 1122 as referred to
NC001653) regions were amplified as previously described [31].Nested PCRs were performed
using primer pairs HDV04-F and HDV05-R for first PCR and primer pairs HDV06-F and
HDV07-R for second PCR (Table 1). PCR reactions were performed at 95˚C for 2 min fol-
lowed by 95˚C for 30 sec, 54˚C for 45 sec, and 72˚C for 45 sec for 35 cycles, with a final exten-
sion for 10 min at 72˚C. The amplicons were visualized on 1.5% agarose-gels. In addition, the
results were verified and validated in another, independent laboratory at 108 Military Central
Table 1. Primers used for HDV detection.
Primers Sequence (5’- 3’) Position PCR round Refs
HDV04-F GGATGCCCAGGTCGGACCG 856–874 1st round PCR [31]
HDV05-R AAGAAGAGRAGCCGGCCCGY 1159–1179 1st round PCR
HDV06-F ATGCCATGCCGACCCGAAGA 888–907 2nd round PCR
HDV07-R GGGGAGCGCCCGGDGGCGG 1104–1122 2nd round PCR
HDV57-F GAGAAMYCACCTCCAGAGGA 299–318 1st round PCR [34]
HDV60-R TCCCATTCGCCATTACCGA 752–770 1st round PCR
HDV48-F AGAGGACCCCTTCAGCGAAC 313–332 2nd round PCR
HDV54-R CCGGGATAAGCCTCACTCG 467–485 2nd round PCR
HBV22-F TGCTGCTATGCCTCATCTTC 414–433 1st round PCR [35]
HBV65-R CAAAGACAAAAGAAAATTGG 822–803 1st round PCR
HBV66-R CACAGATAACAAAAAATTGG 822–803 1st round PCR
HBV24-F CAAGGTATGTTGCCCGTTTGTCCT 455–478 2nd round PCR
HBV41-R GGACTCACGATGCTGTACAG 786–767 2nd round PCR
HBV64-R GGACTCAMGATGYTGCACAG 786–767 2nd round PCR
https://doi.org/10.1371/journal.pone.0175304.t001
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hospital and reference Centre in Hanoi, Vietnam, which is certified for hepatitis molecular
diagnostics. The PCR amplicons were subsequently used for sequencing to determine patient-
specific HDV isolates.
Quantification of HBV and HBV genotyping
Total viral nucleic acids extracted from 200 μL sera were used for HBV quantification and geno-
typing. HBV quantification was performed using HBV Real-TM Quant Dx (Sacace Biotechnol-
ogies, Como, Italy) following the manufacturer´s instructions. HBV genotyping was performed
using nested PCR as described [36]. The first round of HBV-specific nested PCR was performed
with 2.0 μL total viral nucleic acids (about 400 ng) using FastStart PCR Master Kit (Roche Diag-
nostics GmbH, Mannheim, Germany), with three primers (HBV22-F, HBV66-R, and HBV65-
R) as described in Table 1. The amplicons from first round were used as templates for the sec-
ond PCR using three nested primers (HBV24-F, HBV64-R, and HBV41-R) as described in
Table 1. Initial denaturation was at 95˚C for 2 min. The PCR thermal conditions were per-
formed as first round (95˚C for 30 sec, 55˚C for 30 sec, and 72˚C for 30 sec for 35 cycles) and
second round (95˚C for 30 sec, 50˚C for 30 sec, and 72˚C for 30 sec for 30 cycles) followed by a
final extension for 10 min at 72˚C for both PCR rounds. The amplicons were visualized on
1.5% agarose-gels and were subsequently used for sequencing to determine patient-specific
HBV genotypes.
Sequencing and phylogenetic analyses
In order to determine patient-specific HDV isolates, PCR products were gel-eluted using the
Gene JET Gel Extraction Kit (ThermoScientific, Lithuania) following the manufacturer’s instruc-
tions. 5 μLof eluted PCR amplicons was subjected to cycle sequencing with 1.0 μLof the ABI
Prism BigDye terminator cycle sequencing ready reaction kit (Applied Biosystems Inc., Foster
city, California, USA) using 0.5 μL of each inner sense and inner antisense primers (HDV48-F/
HDV54-R, and HDV06-F/HDV07-R) on a ABI 3500 Automated Genetic Analyser (Applied
Biosystems Inc., Foster city, California, USA).Consensus sequences were generated by alignment
of both sequenced strands with forward/sense and reverse/antisense primers after validation
using BioEdit 9.7 and DNAstar software V7. The phylogenetic tree was reconstructed from
nucleotide sequences using the MEGA 7 software [37]. The phylogenetic tree was reconstructed
using the Neighbor-Joining tree methodology that utilizes maximum likelihood approach.
For alignment and HDV genotyping, eight prototype HDV-sequences retrieved from the
NCBI GenBank were used (HDV-1: AF098261, AJ000558, AY633627, HM046802, NC001653,
KF660600, KF660601, KF660602; HDV-2: KF660599, AF104264, AF425645, AY261457, AY26
1459, AF261460; HDV-3: AB037947, AB037948, AB037949; HDV-4: AF018077, AF209859;
HDV-5: AM183326, AM183331, JA417551; HDV-6: AJ584847, AM183332; HDV-7: AM183
333, JA417541; HDV-8: AM183327, AM183330).
For alignment and HBV-genotyping, seven HBV-genotype sequences retrieved from the
NCBI GenBank were used (HBV genotype A: Z72478, KU605532; HBV genotype B: D00330,
AB033554; HBV genotype C: AY040627, X52939; HBV genotype D: KT235604, AY233296;
HBV genotype E: X75657, AB032431; HBV genotype F: AB036920, AB036910; HBV genotype
G: AB056515, AF405706).
Statistical analysis
Statistical analysis was performed by using R software (http://www.r-project.org). Categorical
data were compared by Fisher´s exact test. Non-parametric data were compared by using the
Mann-Whitney U test, with a 2-tailed p-value <0.05 considered to be statistically significant.
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Results
Baseline characteristics of the HBsAg-positive patients
This cross-sectional study was performed on 250 chronic HBsAg-positive patients in South
Central Vietnam. Of the investigated study subjects, 169/250 (68%) were male and 81/250
(32%) were female individuals. The median age of the patients was 36 (11–76 years). The
median HBV loads were 4.4 [2.4–9.2 (log10 HBV-DNA)]. The median of serum alanine ami-
notransferase (ALT), aspartate aminotransferase (AST) levels, and total and direct bilirubin
concentrations were 27 IU/L (10–591), 24 IU/L (9–974), 7.8 μmoL/L (2.2–59.1), 3.0 μmoL/L
(0.3–40.5), respectively (Table 2).
HDV infection in chronic hepatitis B patients
In order to diagnose a HDV infection in chronic HBsAg-positive patients, a recently described
sensitive and specific-HDV nested PCR methodology was employed (Fig 1). Alignment of the
nested HDV primer sequences showed that the sequences are highly conserved between differ-
ent HDV-strains and HDV-genotypes of different geographic areas (Fig 1). The HDV nested
PCR amplifies a region in the HDV genome which is localized between nucleotides (nt) 313 to
nt 485 (numbering is referred to NC001653) that yields an amplicon size of 172 bp (Fig 1).
HDV-RNA was detected in 25/250 (10%) chronic HBsAg-positive patients. Of the 25 HDV
positive patients, 15/25 were male (60%) and 10/25 were female (40%). The median age of the
HDV-HBV coinfected patients was 38 (22–62 years), and there was no significant difference
between males 35 (24–50 years) and females 41.5 (22–62 years) (Table 2).
Association with HDV infection and HBV genotypes
In order to determine the distribution of HBV genotypes in HDV positive patients, the
HDV-HBV coinfected samples were further selected for HBV genotypes. HBV-genotyping
showed that HBV-genotypes B (22/25; 88%) and C (3/25; 12%) were predominant (Table 3
and Fig 2). Other HBV genotypes were not detected in this study population. We also com-
pared HBV loads between HBV genotypes within HDV positive samples. HBV loads were not
significantly distributed between HBV genotypes (HBV-genotype B vs. C: 5.14 ± 2.29 log10
copies/mL vs. 6.37 ± 1.96 log10 copies/mL; P = 0.39) (data not shown).
HDV and chronic HBV infection clinical outcomes
The clinical and subclinical characteristics of the patients with or without HDV infection were
presented in Table 2 and Fig 3. The mean age did not differ between two groups (P = 0.52).
Table 2. Baseline data and clinical characteristics of the HBV patients.
Characteristics HBV positive (n = 250) HDV negative (n = 225) HDV positive (n = 25)
Age (years) 36 (11–76) 36 (11–76) 38 (22–62)
Gender (male/female) 169/81 154/71 15/10
ALT (IU/L) 27 (10–591) 28 (10–591) 22 (10–253)
AST (IU/L) 24 (9–974) 23 (10–974) 24 (9–176)
Total Bilirubin (μmoL/L) 7.8 (2.2–59.1) 7.7 (2.2–59.1) 8.3 (2.8–27.6)
Direct Bilirubin (μmoL/L) 3.0 (0.3–40.5) 2.9 (0.3–40.5) 3.1 (1.2–11.5)
HBV load (log10 copies/mL) 4.4 (2.4–9.2) 4.4 (2.4–9.2) 4.7 (2.5–8.7)
IU: international unit; data are given as median with range; ALT: alanine aminotransferase; AST: aspartate aminotransferase. P values are presented for
comparisons between HDV negativity vs. HDV positivity.
https://doi.org/10.1371/journal.pone.0175304.t002
HDV prevalence in Central Vietnam
PLOS ONE | https://doi.org/10.1371/journal.pone.0175304 April 12, 2017 5 / 15
Fig 1. Nested HDV specific RT-PCR. (a) Primers for HDV-specific nested PCRs were selected in highly
conserved regions of the HDV genome. For detecting HDV RNA genomes, primers HDV57-F and HDV60-R
HDV prevalence in Central Vietnam
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The aminotransferase enzymes (ALT and AST: 43.6 IU/L and 35.0 IU/L vs. 43.5 IU/L and 36.3
IU/L, respectively; P>0.05) as well as total bilirubin (8.5 μmoL/L vs. 8.7 μmoL/L), and direct
bilirubin (3.5 μmoL/L vs. 3.4 μmoL/L) were not significantly higher in HDV positive compared
to HDV negative HBV-infected patients (P>0.05). The HBV-DNA loads were not significantly
higher in HDV negative patients in comparison to HBV-HDV coinfected patients (5.0 log10
copies/mL vs. 5.3 log10 copies/mL; P = 0.42).
Although HDV-1 seems to be less predominant in comparison with the HDV-2 in this
study, patients with HDV-1 showed higher HBV-DNA loads as compared to those with HDV-
were used for first PCR round, HDV48-F and HDV54-R were used for nested PCR [34]. (b) For HDV genotyping,
primers HDV04-F and HDV05-R were used for the first round, primers HDV06-F and HDV07-R were used for
nested PCR [31]. The primers matched with reference sequences of eight prototype HDV genotypes retrieved
from the NCBI-GenBank. The primer sequences target to two different regions of the HDV genome. The
numbers 1 to 8 in (a) and (b) of each reference sequence indicate the respective HDV genotypes 1 to 8. (c)
Schematic representation of the HDV genome and primer binding sites. R1, R2 = ribozyme domain; C = C-
terminal amino acid extension; A = PolyA. HDAg: hepatitis delta antigen; E = RNA editing site (position at nt
1015) [38]. Numbering is according to HDV strain NC1001653. (d) Representative agarose gel electrophoresis of
amplified HDV products from nested-PCR using primers indicated in Fig 1B. The final PCR product length is 234
bp. HDV positive samples were identified in lanes 7 and 12. P, positive control was amplified from a full-length
HDV plasmid (lane 18). N, negative control (lane 19). M, marker.
https://doi.org/10.1371/journal.pone.0175304.g001
Table 3. Distribution of HBV and HDV genotypes in HBV-HDV coinfected individuals.
Nr. Sample ID Age Gender HBV load1 (copies/mL) HBV genotype HDV genotype
1 HM008 28 Female 8.7 B 1
2 HM014 22 Female 8.4 B 1
3 HM049 33 Male 8.4 C 1
4 HM052 41 Male 7.7 B 1
5 HM080 62 Female 3.7 B 1
6 HM054 34 Male 4.4 B 2
7 HM062 45 Female 5.7 B 2
8 HM067 45 Male 5.7 B 2
9 HM095 39 Male 3.2 B 2
10 HM115 24 Male 7.9 B 2
11 HM116 24 Male 6.2 C 2
12 HM121 32 Male 3.7 B 2
13 HM122 35 Male 6.0 B 2
14 HM137 31 Male 4.7 B 2
15 HM141 56 Female 6.0 B 2
16 HM146 38 Female 8.7 B 2
17 HM149 39 Male 4.5 C 2
18 HM178 36 Female 8.6 B 2
19 HM195 51 Female 2.9 B 2
20 HM223 26 Female 2.8 B 2
21 HM224 32 Male 2.6 B 2
22 HM232 59 Female 3.7 B 2
23 HM233 48 Male 2.7 B 2
24 HM239 50 Male 2.5 B 2
25 HM240 43 Male 2.8 B 2
1values are given as log10 copies/mL
https://doi.org/10.1371/journal.pone.0175304.t003
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Fig 2. Phylogenetic analyses of HBV genomes in South Central Vietnamese HBsAg-positive patients.
Phylogenetic tree was inferred from distance analysis (Kimura 2 parameters model) and neighbor-joining recon-
struction from S gene region of HBV sequence (nt 455–786, numbering is referred to HM011485). South Central
Vietnamese HBV sequences are referred to as “letter/number”, i.e., “HM115”. The South Central Vietnamese HBV
sequences were compared to HBV reference sequences, gathering the seven HBV genotypes (GenBank access-
ion numbers are denoted in the figure). Phylogenetic analysis of HBV region nt455 to nt 786 showed that the HDV
sequences were clustered in the Asian HBV-genotype branches 1 and 4.
https://doi.org/10.1371/journal.pone.0175304.g002
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2 (median log10 (HBV-DNA copies/ml): 8.4 vs. 4.5, P = 0.036, Fig 3A). Other liver parameters
including AST, ALT (Fig 3B and 3C) as well as bilirubin (data not shown) levels were not sig-
nificantly different between two groups of HDV-1 and HDV-2 patients (P>0.05).
Distribution of HDV genotypes
The sequences of the 25 HDV-RNA-positive samples that amplified HDAg are illustrated in
Fig 4A. Patient-specific HDV isolates were confirmed by sequence variations of the analysed
HDAg gene region (Fig 4B; all sequences were submitted to the GenBank Database and the
Accession number allotted from KX897956 to KX897980). Phylogenetic analysis was per-
formed using sequences of the HDV amplicons and analysis showed that all analyzed HDV
genotypes belong to either HDV-1 or HDV-2. The HDV strains also clustered in the Asian
clade. Notably, 20/25 (80%) HDV isolates fit into the clade of genotype 2 (Fig 4B).
Discussion
Nearly 40 years after discovery of HDV, the disease caused by this virus yet remains a major
problemin regions where HBV is endemic. There are so far no recommended standard therapy
and diagnosis in place for HDV treatment in Vietnam. The incidence of HDV and its interac-
tion with HBV carriers is sparsely reported in Central Vietnam, a HBV endemic region. HDV
incidences and prevalences are under reported in several Asian countries where HBV is
endemic and the significance of HDV infection is poorly studied in Vietnam. This very first
study provides epidemiological data on HDV infection in Central Vietnam, with a higher
representation of HDV-2 among chronic HBV patients.
In European countries, HDV prevalence has diminished because of available HBV antiviral
therapies and due to the successful implementation of HBV vaccination regimen [39]. How-
ever, recently, an increasing number of reports claim that HDV incidence is at rise because of
increased influx of immigrants from HBV and HDV endemic areas [6, 40] and,therefore, an
increased HDV seroprevalence exist (8–20%) [6, 41, 42].In Asia, the HDV infection have been
reported in Mongolia (56.5%), Pakistan (60%), India (37%), and China (15%) [28, 43–45].
However in other Asian countries such as Korea (0.32%), Indonesia (<0.5%), and Philipines
(1.6%), a low HDV prevalence is reported [43, 46, 47].
The hepatitis delta virus distribution varies across different geographical regions and even
within a country [6, 14]. For example, the prevalence of HDV infection in HBsAg-positive
individuals varied between Western and South Eastern regions of Turkey (5% vs. 27%) [48].
Such intra-regional distributions are likely within a country.In the presented study, we
Fig 3. Association with HDV genotypes and clinical parameters in 25 HBV-HDV coinfections. The
distribution of HBV-DNA loads (A), ALT levels (B), and AST levels (C) according to HDV genotypes. P values
were calculated by Mann-Whitney-Wilcoxon test. NS = not significant.
https://doi.org/10.1371/journal.pone.0175304.g003
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Fig 4. Phylogenetic analyses of HDV genomes in chronic HBsAg-positive patients in South Central
Vietnam. (a) Representative HDV sequences of South Central Vietnamese HBV-HDV infection patients
showing patient-specific HDV isolates. (b) Phylogenetic tree was inferred from distance analysis (Kimura 2
parameters model) and neighbor-joining reconstruction from HDV-region sequences. South Central
Vietnamese HDV sequences are referred to as “letter/number”, i.e., “HM115”. The South Central Vietnamese
HDV sequences were compared to HDV reference sequences, gathering the eight HDV clades (GenBank
accession numbers are denoted in the figure). Phylogenetic analysis of HDV region nt 888 to nt 1122 showed
that the HDV sequences were clustered in the Asian HDV-branches 1 and 5.
https://doi.org/10.1371/journal.pone.0175304.g004
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observed that HDV-RNA prevalence is 10% in HBsAg-positive patients compared to a previ-
ous study that reported 15% HDV-RNA positive cases among HBsAg cariers in Northern
Vietnam [31]. This difference might be due to the region-related burden of the disease or may
likely result from the different cohorts of these two studies. In a previous study, hospitalized
patients with severe and advanced liver diseases including acute hepatitis, active chronic hepa-
titis, liver cirrhosis and liver cancer were selected. In this study, we selected HBsAg-positive
patients presenting mild hepatitis. HDV was determined as a culprit for more severe hepatitis
than HBV monoinfection which can accelerate the progression of chronic hepatitis B to cir-
rhosis and HCC [49, 50].
Thus far, eight major HDV clades have been identified and distributed over different geo-
graphic areas [8]. Overall, HDV-1 is the most common, which is distributed worldwide and
has a broad spectrum of pathogenecity [8, 51], whereas HDV-2 to 8 seem to occur more
regionally; however, HDV-2 is mainly found in East Asia such as Japan [8, 20]. Although
HDV-1 and -2 circulate in Northern Vietnam as reportedearlier, HDV-1 represents a major
genotype (HDV-1: 91% vs. HDV-2: 9%) [31]. Surprisingly, the results of this current study
showed a contradictory pattern of molecular epidemiology with predominance of HDV-2
comapared to HDV-1 (HDV-2: 80% vs. HDV-1: 20%). Therefore, we speculate that the distri-
bution of HDV genotypes might differ from region to region as seen in Central Vietnam and
Northern Vietnam. However, further studies with a larger samplesizeare needed to confirm
this differential distribution of HDV genotypes across regions within Vietnam.
Several studies have concluded that chronic hepatitis D can exacerbate the pre-existing liver
damage leading to a rapid progression to liver cirrhosis and liver cancer compared to chronic
hepatitis B monoinfection or chronic hepatitis C [1, 3, 4]. Heidrich et al has been demon-
strated that, in the clinical course of HBV-HDV coinfection, HBV-DNA levels are frequently
low, suggesting inhibitory effects of HDV on HBV regardless of the phase of HBV infection
[52]. In addition, among many viral and host factors, HDV genotypes may also contribute to
the clinical course and influences the liver disease outcomes. HDV-1 is associated with both
severe and mild course, while HDV-2 induces a mild course [14]. Another study investigated
the impact of HDV-1 and -2 on clinical implications in HBV-infected patients. The results
showed that patients infected with HDV-2 had significantly lower ALT levels and a trend to
have lower serum HDV-RNA levels as compared with those infected with HDV-1 [51]. In
line with mentioned studies, we showed that the levels of HBV-DNA were higher in HDV-1
patients than in HDV-2 patients. This finding could not reflect fully the clinical significance of
HDV towards the clinical outcome of HBV-HDV coinfection due to a relatively small number
of HDV positive patients in this cohort. HDV-1 patients were younger than HDV-2 patients
in the analyzed patient cohort. Therefore it could not be excluded that the difference in viral
loads could be also due to, e.g., an age effect and should be investigated in larger studies.
Although, our current study has characterized the molecular epidemiology of HDV in Cen-
tral Vietnam, our study has limitations. Firstly, this study is designed as a cross-sectional study
and therefore we could not follow up the positve HDV patients over the course of HBV-HDV
coinfection. Secondly, we could not assess in detail the influences of HDV infection on the
clinical significance and the severity of liver diseases in HBV-HDV coinfection. This might be
due to the small sample size and the absence of severe forms of liver diseases, including liver
cirrhosis and hepatocellular carcinoma, of the HBsAg-positive outpatients. Importantly, liver
biopsies are not available in order to measure the accumulation of the intrahepatic replication
intermediates of HBV and HDV.
Our study explored the molecular epidemiology of HDV in Central Vietnam which is to
the best of our knowledge the first report with respect to this highly HBV endemic region of
Vietnam. Our findings indicate that HDV infection is highly prevalent in which HDV-2 is
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predominant in Central Vietnam. This study provides new insights into the prevalence and
genotype distribution as well as risk of HDV infection in Central Vietnam However, further
studies need to be conducted to understand the molecular epidemiology of HDV in different
regions in Vietnam.
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